ECHA’s Candidate List table pages include a transition notice indicating Candidate List regulatory information is available in ECHA CHEM and that ECHA will keep the legacy Candidate List dataset/table up to date until July 2026. This affects compliance operations that rely on the legacy Candidate List table for SVHC screening, Article 33 communication workflows, and system integrations; teams should plan to validate and, if needed, migrate data sourcing to ECHA CHEM while maintaining continuity during the parallel-run period.
ECHA opened a public consultation on its draft 13th recommendation to include certain SVHC Candidate List substances in REACH Annex XIV (Authorisation List). This is an upstream step toward potential Annex XIV inclusion (which would later impose authorisation requirements and set latest application and sunset dates via subsequent Commission action). Compliance teams should review whether any recommended substances are used in products/processes and consider submitting comments and preparing for potential authorisation planning and supply-chain communication.
ECHA launched a public consultation on its draft recommendation to the European Commission to add four Candidate List substances to the REACH Authorisation List (Annex XIV). Compliance teams should monitor this pipeline step because Annex XIV inclusion can introduce authorisation obligations for continued use/placing on the market (subject to future sunset dates set in any eventual Annex XIV entries). The consultation is open for stakeholder input until 2 May 2026.
ECHA published supporting documents for its Draft 13th Recommendation of priority substances for potential inclusion in REACH Annex XIV (Authorisation List), including draft Annex XIV entry structures and background/prioritisation documents. This is a draft/pipeline step (not yet a binding Annex XIV amendment), but it signals which SVHCs may be advanced toward authorisation requirements, informing early substitution planning and monitoring of latest application date/sunset date proposals once finalized by the European Commission.
ECHA opened a public consultation on its 13th draft recommendation for prioritising Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation runs from 2 February 2026 to 2 May 2026. If finalised and later adopted by the European Commission, Annex XIV inclusion would introduce authorisation obligations (including latest application and sunset dates). Compliance teams should review the draft recommendation and background documents, assess portfolio impacts for listed SVHCs, and consider submitting comments.
ECHA opened a public consultation on its 13th draft recommendation for prioritising SVHCs for inclusion in REACH Annex XIV (Authorisation List). The recommendation status is shown as 'included in draft recommendation' with a consultation window from 02-Feb-2026 to 02-May-2026. While this is not yet a binding Annex XIV amendment, it is a key step toward future authorisation requirements (e.g., eventual latest application and sunset dates) for substances selected by the European Commission. Compliance teams should review whether any listed substances are used in their products/processes and consider submitting comments during the consultation period and preparing for potential downstream authorisation impacts if the Commission proceeds.
ECHA has opened a public consultation on its draft 13th recommendation of priority SVHCs from the Candidate List for possible inclusion in REACH Annex XIV (Authorisation List). The consultation window shown is 02 February 2026 through 02 May 2026. This is a key step in the SVHC-to-authorisation pipeline; if substances are later added to Annex XIV by the European Commission, authorisation requirements could apply for non-exempt uses after future latest application/sunset dates. Compliance teams should evaluate business impacts, substitution plans, and consider submitting comments/evidence during the consultation period.
ECHA opened a public consultation on its draft 13th recommendation for inclusion of certain Candidate List SVHCs in REACH Annex XIV (Authorisation List). This is a key SVHC-related downstream step: substances recommended for Annex XIV can later be added by the European Commission via amendment, triggering authorisation requirements (including latest application and sunset dates) for continued use. Consultation window shown is 02 Feb 2026 to 02 May 2026, with linked draft recommendation and supporting documents.
ECHA opened a public consultation on its draft 13th recommendation for prioritising certain Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation period runs from 2 February 2026 to 2 May 2026. This is a key SVHC-to-authorisation pipeline milestone: affected manufacturers/importers/downstream users should review whether any of the recommended substances are in their supply chains and consider submitting comments, as future Annex XIV inclusion can lead to authorisation obligations and phase-out pressures.
ECHA published the Draft 13th Recommendation and opened a public consultation (2 Feb 2026 to 2 May 2026) on prioritising four SVHCs for potential inclusion in the REACH Authorisation List (Annex XIV): bumetrizole (UV-326), UV-329, triphenyl phosphate, and 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one. This consultation is a key step in the SVHC-to-authorisation pathway; affected companies should assess uses and consider submitting evidence on uses, alternatives, and socio-economic impacts.
ECHA published the draft 13th recommendation for inclusion of Candidate List substances of very high concern (SVHCs) in REACH Annex XIV (Authorisation List) and opened a public consultation. This is a key downstream step in the SVHC pathway because Annex XIV listing can ultimately require companies to obtain authorisation for continued use/placing on the market of listed substances after specified sunset dates (once Annex XIV is formally amended via EU legislation). Compliance teams should review whether any substances relevant to their portfolios are covered and consider preparing comments and internal substitution/authorisation strategies.
ECHA opened a public consultation on its draft recommendation to the European Commission to include four SVHC Candidate List substances in REACH Annex XIV (Authorisation List). Stakeholders are invited to submit information (e.g., uses, volumes, potential exemptions, and supply chain impacts) to inform ECHA’s final recommendation. This is a proposed/pipeline step (not yet a legal Annex XIV amendment) but is highly relevant for companies using these substances, as Annex XIV listing can lead to authorisation obligations and potential phase-out/substitution planning.
ECHA reported that its Member State Committee agreed to identify n-hexane as a Substance of Very High Concern (SVHC). This committee agreement is a formal REACH SVHC process milestone that precedes Candidate List inclusion and signals that downstream obligations (e.g., article communication/notification once listed) are expected to follow when ECHA updates the Candidate List accordingly.
ECHA published highlights from its Member State Committee (MSC) December meeting noting agreement to identify n-hexane as a substance of very high concern (SVHC). This is a formal step in the SVHC identification process under REACH and signals likely downstream Candidate List inclusion, which is relevant for companies to anticipate future Article 33 communication and related supply-chain compliance impacts once formally listed.
ECHA issued Decision D(2025)7771-DC dated 11-Dec-2025 to include substances of very high concern in the REACH Candidate List, with publication/update and decision effect stated as 04-Feb-2026. The decision supports the Candidate List update adding n-hexane (Article 57(f)) and 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and its salts (Article 57(c)). Compliance teams should treat the Candidate List inclusion date as the point at which article/SDS and supply-chain communication controls must reflect the updated SVHC status.
On 18 November 2025, ECHA published its 12th Recommendation for inclusion of substances in Annex XIV (Authorisation List) under REACH. Substances recommended include Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide (EC 278-355-8, CAS 75980-60-8), identified as toxic for reproduction under Article 57(c). The European Commission will make the final decision on inclusion. Companies using these substances should prepare for potential authorisation requirements if the Commission adopts the recommendation.
ECHA published its 12th Recommendation for inclusion of substances in Annex XIV (List of Substances subject to Authorisation). This recommendation identifies priority substances from the Candidate List that will require authorization for continued use. Companies using or placing these substances on the EU market should prepare for potential authorization requirements, including sunset dates and application deadlines that will be set by the European Commission when adopting the recommendation.
ECHA published its recommendation dated 18 November 2025 to the European Commission to include four SVHCs in REACH Annex XIV (Authorisation List): Melamine; S-(tricyclo[5.2.1.0²,⁶]deca-3-en-8(or 9)-yl) O-(isopropyl/isobutyl/2-ethylhexyl) O-(isopropyl/isobutyl/2-ethylhexyl) phosphorodithioate; Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide; and Barium diboron tetraoxide. This is a pre-legislative step that can lead to future authorisation requirements (latest application/sunset dates) if adopted into Annex XIV by the European Commission. Compliance teams should track these substances and evaluate potential substitution/authorisation strategies.
ECHA issued its final (12th) recommendation to the European Commission to include four Candidate List SVHCs in REACH Annex XIV (Authorisation List). While this is not yet a binding Annex XIV amendment, it is a concrete step in the SVHC-to-authorisation pipeline and signals potential future authorisation obligations (i.e., continued use/placing on the market after any future sunset dates would require authorisation unless exemptions apply). Compliance teams should monitor the Commission’s subsequent Annex XIV amendment process and begin evaluating uses and substitution plans for the recommended substances.
ECHA added DBDPE (EC 284-366-9; CAS 84852-53-9) to the REACH Candidate List as an SVHC on vPvB grounds (Article 57(e)). This triggers downstream SVHC obligations for supply-chain communication (Article 33) for articles containing the SVHC above 0.1% w/w, potential ECHA article notification duties where applicable, and Safety Data Sheet updates for EU/EEA suppliers of the substance (as such or in mixtures). Compliance teams should update substance and article SVHC screening, supplier declarations, and customer communication processes accordingly.